Abstract
Biotechnology is a topic of considerable diversity and implications for the future, if not the very philosophy, of health care. In many respects, biotechnology differs markedly from traditional sources of new therapeutic agents. Biotechnology is viewed as encompassing three major areas: genetic engineering, molecular synthesis, and drug delivery systems. Each of these a as is an important source of pharmacologic agents. The implications for biotechnology for the drug development process are examined with particular reference to opportunities for the statistician or bio-statistician to contribute.
| Original language | American English |
|---|---|
| Pages (from-to) | 499-513 |
| Number of pages | 15 |
| Journal | Therapeutic Innovation and Regulatory Science |
| Volume | 22 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 1 1988 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Scopus Subject Areas
- Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
- Public Health, Environmental and Occupational Health
- Pharmacology (medical)
Disciplines
- Public Health
- Biostatistics
Keywords
- Biostatistics
- Biotechnology
- Drug development
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver